British Journal of Dermatology

Research Snippets
pp. viii-viii(1)

Adalimumab: a new alternative biologic agent for chronic plaque psoriasis
pp. 435-436(2)
Author: Ormerod, AnthonyD.

Explaining phenotype heterogeneity in patients with psoriasis
pp. 437-441(5)
Author: Christophers, E.

Skin microbiota: a source of disease or defence?
pp. 442-455(14)
Authors: Cogen, A.L.; Nizet, V.; Gallo, R.L.

Anti-lymphocyte function associated antigen-1 inhibits T-helper 2 function of human allergen-specific CD4+ T cells
pp. 456-462(7)
Authors: Ardern-Jones, M.R.; Black, A.P.; Ogg, G.S.

Binding of avian IgY to type VII collagen does not activate complement and leucocytes and fails to induce subepidermal blistering in mice
pp. 463-471(9)
Authors: Sesarman, A.; Mihai, S.; Chiriac, M.T.; Olaru, F.; Sitaru, A.G.; Thurman, J.M.; Zillikens, D.; Sitaru, C.

Repair of photoaged dermal matrix by topical application of a cosmetic `antiageing' product
pp. 472-477(6)
Authors: Watson, R.E.B.; Long, S.P.; Bowden, J.J.; Bastrilles, J.Y.; Barton, S.P.; Griffiths, C.E.M.

Cervicovaginal involvement in pemphigus vulgaris: a clinical study of 77 cases
pp. 478-482(5)
Authors: Akhyani, M.; Chams-Davatchi, C.; Naraghi, Z.; Daneshpazhooh, M.; Toosi, S.; Asgari, M.; Malekhami, F.

Analysis of the VCX3A, VCX2 and VCX3B genes shows that VCX3A gene deletion is not sufficient to result in mental retardation in X-linked ichthyosis
pp. 483-486(4)
Authors: Cuevas-Covarrubias, S.A.; González-Huerta, L.M.

The clinical relevance of serum antinuclear antibodies in Japanese patients with systemic sclerosis
pp. 487-495(9)
Authors: Hamaguchi, Y.; Hasegawa, M.; Fujimoto, M.; Matsushita, T.; Komura, K.; Kaji, K.; Kondo, M.; Nishijima, C.; Hayakawa, I.; Ogawa, F.; Kuwana, M.; Takehara, K.; Sato, S.

Effect of proteasome inhibitors on proliferation and apoptosis of human cutaneous melanoma-derived cell lines
pp. 496-504(9)
Authors: Sorolla, A.; Yeramian, A.; Dolcet, X.; Pérez de Santos, A.M.; Llobet, D.; Schoenenberger, J.A.; Casanova, J.M.; Soria, X.; Egido, R.; Llombart, A.; Vilella, R.; Matias-Guiu, X.; Marti, R.M.

Increased expression of interleukin-23 p19 mRNA in erythema nodosum-like lesions of Behçet's disease
pp. 505-511(7)
Authors: Lew, W.; Chang, J.Y.; Jung, J.Y.; Bang, D.

Follow-up analysis of 180 Chinese Han families: identification of a novel locus for psoriasis at 2p22.3-11.2
pp. 512-517(6)
Authors: Sun, L.D.; Yang, S.; Liu, J.J.; Ren, Y.Q.; Fan, X.; Xu, S.X.; Zhou, L.; Yang, C.J.; Xiao, F.L.; Gao, M.; Cui, Y.; Du, W.H.; Huang, W.; Zhang, X.J.

A review of 241 subjects who were patch tested twice: could fragrance mix I cause active sensitization?
pp. 518-521(4)
Authors: White, J.M.L.; McFadden, J.P.; White, I.R.

Perioperative international normalized ratio level is a poor predictor of postoperative bleeding complications in dermatological surgery patients taking warfarin
pp. 522-526(5)
Authors: Blasdale, C.; Lawrence, C.M.

Expression profiling of microdissected cell populations selected from basal cells in normal epidermis and basal cell carcinoma
pp. 527-538(12)
Authors: Asplund, A.; Gry Björklund, M.; Sundquist, C.; Strömberg, S.; Edlund, K.; Östman, A.; Nilsson, P.; Pontén, F.; Lundeberg, J.

Prevalence and risk factors for atopic dermatitis in preschool children
pp. 539-543(5)
Authors: Peroni, D.G.; Piacentini, G.L.; Bodini, A.; Rigotti, E.; Pigozzi, R.; Boner, A.L.

Attributes of an effective trainer: implications of the views of U.K. dermatology trainees
pp. 544-548(5)
Authors: Farrant, P.; Cohen, S.N.; Burge, S.M.

Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis
pp. 549-557(9)
Authors: Revicki, D.; Willian, M.K.; Saurat, J.-H.; Papp, K.A.; Ortonne, J.-P.; Sexton, C.; Camez, A.

Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION)
pp. 558-566(9)
Authors: Saurat, J.-H.; Stingl, G.; Dubertret, L.; Papp, K.; Langley, R.G.; Ortonne, J.-P.; Unnebrink, K.; Kaul, M.; Camez, A.

An open-label phase II study of the safety and efficacy of etanercept for the therapy of hidradenitis suppurativa
pp. 567-572(6)
Authors: Giamarellos-Bourboulis, E.J.; Pelekanou, E.; Antonopoulou, A.; Petropoulou, H.; Baziaka, F.; Karagianni, V.; Stavrianeas, N.; Giamarellou, H.

The efficacy of aloe vera gel in the treatment of oral lichen planus: a randomized controlled trial
pp. 573-577(5)
Authors: Choonhakarn, C.; Busaracome, P.; Sripanidkulchai, B.; Sarakarn, P.

Antitumour effects in mycosis fungoides of the immunomodulatory, tellurium-based compound, AS101
pp. 578-586(9)
Authors: Frei, G.M.; Kremer, M.; Hanschmann, K.-M.; Krause, S.; Albeck, M.; Sredni, B.; Schnierle, B.S.

Genotyping of HLA-I and HLA-II alleles in Chinese patients with paraneoplastic pemphigus
pp. 587-591(5)
Authors: Liu, Q.; Bu, D-F.; Li, D.; Zhu, X-J.

Hand-foot skin reaction in patients treated with sorafenib: a clinicopathological study of cutaneous manifestations due to multitargeted kinase inhibitor therapy
pp. 592-596(5)
Authors: Yang, C-H.; Lin, W-C.; Chuang, C-K.; Chang, Y-C.; Pang, S-T.; Lin, Y-C.; Kuo, T-T.; Hsieh, J-J.; Chang, J.W.C.

A case of acute radiation syndrome from the dermatological aspect
pp. 597-602(6)
Authors: Hoashi, T.; Okochi, H.; Kadono, T.; Tamaki, K.; Nishida, M.; Futami, S.; Maekawa, K.

Ichthyosiform erythroderma with rickets: report of five cases
pp. 603-606(4)
Authors: Sethuraman, G.; Khaitan, B.K.; Dash, S.S.; Chandramohan, K.; Sharma, V.K.; Kabra, M.; Verma, K.K.; Goswami, R.; Thulkar, S.

Gadolinium-induced nephrogenic systemic fibrosis in a patient with an acute and transient kidney injury
pp. 607-610(4)
Authors: Kalb, R.E.; Helm, T.N.; Sperry, H.; Thakral, C.; Abraham, J.L.; Kanal, E.

Novel and recurring ABCA12 mutations associated with harlequin ichthyosis: implications for prenatal diagnosis
pp. 611-613(3)
Authors: Thomas, A.C.; Sinclair, C.; Mahmud, N.; Cullup, T.; Mellerio, J.E.; Harper, J.; Dale, B.A.; Turc-Carel, C.; Hohl, D.; McGrath, J.A.; Vahlquist, A.; Hellstrom-Pigg, M.; Ganemo, A.; Metcalfe, K.; Mein, C.A.; O'Toole, E.A; Kelsell, D.P.

Three novel mutations of the EDA gene in Chinese patients with X-linked hypohidrotic ectodermal dysplasia
pp. 614-617(4)
Authors: Zhao, J.; Hua, R.; Zhao, X.; Meng, Y.; Ao, Y.; Liu, Q.; Shang, D.; Sun, M.; Lo, W.H-Y.; Zhang, X.

A splicing mutation in the COL7A1 gene causes autosomal dominant dystrophic epidermolysis bullosa pruriginosa
pp. 618-620(3)
Authors: Ren, X.; Liu, J.Y.; Zhai, L.Y.; Yao, Q.; Dai, X.; Cai, Z.; Liu, P.; Sun, K.; Huang, C.; Wang, Q.K.; Liu, M.

A novel missense mutation in RSPO4 gene underlies autosomal recessive congenital anonychia in a consanguineous Pakistani family
pp. 621-623(3)
Authors: Chishti, M.S.; Kausar, N.; Rafiq, M.A.; Amin, M.; Ahmad, W.

Paracoccidioidomycosis presenting in the U.K.
pp. 624-626(3)
Authors: Walker, S.L.; Pembroke, A.C.; Lucas, S.B.; Vega-Lopez, F.

Cutaneous neonatal lupus erythematosus in four siblings
pp. 626-628(3)
Authors: Monari, P.; Gualdi, G.; Fantini, F.; Giannetti, A.

Anastrozole-induced subacute cutaneous lupus erythematosus
pp. 628-629(2)
Authors: Trancart, M.; Cavailhes, A.; Balme, B.; Skowron, F.

Adrenergic urticaria in a patient with cholinergic urticaria
pp. 629-631(3)
Authors: Mihara, S.; Hide, M.

Increase in nuclear translocation of nuclear transcription factor-κB following infection of a human Schwann cell line with Leishmania amazonensis
pp. 631-633(3)
Authors: Baetas-Da-Cruz, W.; Castro, P.; Guimarães, E.V.; Koatz, V.L.G.; Corte-Real, S.; Cavalcante, L.A.

Severity of psoriasis and health-related quality of life: the moderating effects of temperament
pp. 633-635(3)
Authors: Janowski, K.; Steuden, S.

Tungiasis: eggs seen with dermoscopy
pp. 635-636(2)
Authors: Cabrera, R.; Daza, F.

MDM2 polymorphisms and cancer risk in basal cell carcinoma
pp. 636-636(1)
Authors: Boyd, M.T.; Vlatković, N.

MDM2 polymorphisms and cancer risk in basal cell carcinoma: reply from authors
pp. 636-637(2)
Authors: Wilkening, S.; Hemminki, K.; Kumar, R.

Telomerase activity in peripheral blood mononuclear cells of psoriatic patients correlates with disease severity
pp. 637-639(3)
Authors: Liu, X.; Lin, J.; Wang, L.; Zhang, Z.; Hou, S.; Yang, G.

The use of dietary manipulation in patients referred to a contact dermatitis clinic
pp. 639-640(2)
Authors: Davis, R.F.; Mortimer, N.J.; Sladden, M.J.; Johnston, G.A.

Chromosomal integration of human herpesvirus 6 DNA in anticonvulsant hypersensitivity syndrome
pp. 640-642(3)
Authors: Watanabe, H.; Daibata, M.; Tohyama, M.; Batchelor, J.; Hashimoto, K.; Iijima, M.

Successful use of etanercept in type I pityriasis rubra pilaris
pp. 642-644(3)
Authors: Seckin, D.; Tula, E.; Ergun, T.

Successful treatment of extensive human papillomavirus-associated oral leucoplakia with imiquimod
pp. 644-646(3)
Authors: Allam, J.P.; Erdsach, T.; Wenghoefer, M.; Bieber, T.; Appel, T.R.; Novak, N.

Childhood lichen planus after simultaneous measles-mumps-rubella and diphtheria-tetanus-pertussis-polio vaccinations
pp. 646-648(3)
Authors: Tasanen, K.; Renko, M.; Kandelberg, P.; Herva, R.; Oikarinen, A.

Leprosy type 1 reaction spares the scars in a patch of borderline tuberculoid leprosy
pp. 648-649(2)
Authors: Walker, S.L.; Lewis, T.G.; Mahat, K.; Hawksworth, R.A.

Evaluation of a novel `needlecatcher' surgical instrument designed to reduce the incidence of needle stick injuries from suture needles during skin suturing
pp. 649-651(3)
Authors: Mckenna, D.J.; McGlennon, S.; McCallum, M.; Dolan, O.M.

Nerve fibres: a possible role in keloid pathogenesis
pp. 651-652(2)
Authors: Hochman, B.; Nahas, F.X.; Sobral, C.S.; Arias, V.; Locali, R.F.; Juliano, Y.; Ferreira, L.M.

Ciclosporin-induced fibrovascular polyps vs. bacillary angiomatosis
pp. 652-653(2)
Authors: Woo, S.-B.; Treister, N.

Pitfalls of prescribing acne therapies including isotretinoin for pilots
pp. 653-655(3)
Authors: Taibjee, S. M.; Charles-Holmes, R.

News and Notices
pp. 655-656(2)

Corrigenda
pp. 657-657(1)

Corrigenda
pp. 657-657(1)

Corrigenda
pp. 657-657(1)